Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision therapeutic targets for COVID-19
Zachary A. Krumm, Grace M. Lloyd, Connor Francis, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
Yuwen Zhou, Yao Xie, Liansha Tang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 100
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
Immune responses in mildly versus critically ill COVID-19 patients
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
Lactoferrin: Antimicrobial impacts, genomic guardian, therapeutic uses and clinical significance for humans and animals
Mohamed E. Abd El‐Hack, Sameh A. Abdelnour, Mahmoud Kamal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114967-114967
Open Access | Times Cited: 22
Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database
Anasua Deb, John Abdelmalek, Kenneth Iwuji, et al.
Journal of Primary Care & Community Health (2021) Vol. 12
Open Access | Times Cited: 49
Environmental and ecotoxicological effects of drugs used for the treatment of COVID 19
Donal Efrain Merma Chacca, Ingrid Maldonado, Franz Zirena Vilca
Frontiers in Environmental Science (2022) Vol. 10
Open Access | Times Cited: 30
COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
Wei Shen Ho, Ruirui Zhang, Yeong Lan Tan, et al.
Pharmacological Research (2022) Vol. 179, pp. 106201-106201
Open Access | Times Cited: 29
Key insights into recent advances and challenges in COVID-19 management
Prakash Monika, Anushka A. Poola, Prithvi S. Prabhu, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
The Chiral 5,6-Cyclohexane-fused Uracil Ring-System: a Molecular Platform with Promising Activity against SARS-CoV-2
Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117302-117302
Closed Access
Revealing the toxicity of lopinavir- and ritonavir-containing water and wastewater treated by photo-induced processes to Danio rerio and Allivibrio fischeri
Bożena Czech, Agnieszka Krzyszczak, Anna Boguszewska‐Czubara, et al.
The Science of The Total Environment (2022) Vol. 824, pp. 153967-153967
Open Access | Times Cited: 26
Conserved recombination patterns across coronavirus subgenera
Arné de Klerk, Phillip Swanepoel, Rentia Lourens, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 26
SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control
Sreus A. G. Naidu, Roger Clemens, A. Satyanarayan Naidu
Journal of Dietary Supplements (2022) Vol. 20, Iss. 2, pp. 312-371
Closed Access | Times Cited: 23
Drugs for COVID-19: An Update
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
Comprehensive eco-geno-toxicity and environmental risk of common antiviral drugs in aquatic environments post-pandemic
Roberta Nugnes, Elena Orlo, Chiara Russo, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 135947-135947
Open Access | Times Cited: 4
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients
Arman Shafiee, Mohammad Mobin Teymouri Athar, Omid Kohandel Gargari, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 21
Bovine lactoferrin inhibits SARS‐CoV‐2 and SARS‐CoV‐1 by targeting the RdRp complex and alleviates viral infection in the hamster model
Shiting He, Hongbo Qin, Lin Guan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Ethnomedicinal, Phytochemistry and Antiviral Potential of Turmeric (Curcuma longa)
Bajarang Bal Lal Srivastava, Asha Ripanda, Hossein Miraji
Compounds (2022) Vol. 2, Iss. 3, pp. 200-221
Open Access | Times Cited: 20
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411
Robert Konkel, Aleksandra Milewska, Thuc Nguyen Dan, et al.
Antiviral Research (2023) Vol. 219, pp. 105731-105731
Open Access | Times Cited: 10
Metal-based complexes against SARS-CoV-2
Kyriakos Ioannou, Manos C. Vlasiou
BioMetals (2022) Vol. 35, Iss. 4, pp. 639-652
Open Access | Times Cited: 16
ENHANCED PHOTOCATALYTIC DEGRADATION OF ANTIVIRAL DRUGS LOPINAVIR AND RITONAVIR BY Ni DOPED ZnO/SiO2 NANOCOMPOSITES
Mariia Galaburda, Michael Nazarkovsky, Karol Osipiuk, et al.
Journal of environmental chemical engineering (2024), pp. 114525-114525
Closed Access | Times Cited: 2
Selection of Suitable Protein Structure from Protein Data Bank: An Important Step in Structure-based Drug Design Studies
Mange Ram Yadav, Prashant R. Murumkar, Mayank Sharma, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 246-264
Closed Access | Times Cited: 12
Annexin A1 as a potential prognostic biomarker for COVID‐19 disease: Case–control study
Ömer Çanacık, Ramazan Sabırlı, Emel Altıntaş, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 10
Open Access | Times Cited: 16
Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against RNA-Dependent RNA Polymerase Complex (nsp7/nsp8/nsp12) of SARS-CoV-2
Sreus A. G. Naidu, Ghulam Mustafa, Roger Clemens, et al.
Journal of Dietary Supplements (2021) Vol. 20, Iss. 2, pp. 254-283
Closed Access | Times Cited: 16
Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants
Sandro Satta, Fahimeh Shahabipour, Wei Gao, et al.
Theranostics (2022) Vol. 12, Iss. 10, pp. 4779-4790
Open Access | Times Cited: 11
Synthesis, Characterization, and Molecular Docking of Casiopeinas® with Dipeptides as Secondary Ligand; Potential Inhibitors of SARS-Cov-2 Transcendental Proteins
Luis Gabriel Talavera-Contreras, Luis Felipe Hernández‐Ayala, Virginia Gómez‐Vidales, et al.
Journal of the Mexican Chemical Society (2024) Vol. 68, Iss. 1, pp. 29-55
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top